Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanoma

Immune checkpoint inhibitors (ICIs) are associated with a range of organ-specific toxicities known as immune-related adverse events (irAEs). Immune-mediated ototoxicity from ICIs is poorly described. Herein, we describe the clinical presentation, diagnostic evaluation and management of six ICI-treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosner, Samuel, Agrawal, Yuri, Sun, Daniel Q, Aygun, Nafi, Schollenberger, Megan D, Lipson, Evan, Naidoo, Jarushka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745691/
https://www.ncbi.nlm.nih.gov/pubmed/33335030
http://dx.doi.org/10.1136/jitc-2020-001675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745691/
https://www.ncbi.nlm.nih.gov/pubmed/33335030
http://dx.doi.org/10.1136/jitc-2020-001675

Ejemplares similares